Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-27

Clinical Trial Update: Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy and safety of millet seed extract as a treatment for telogen effluvium. The trial is registered as NCT0734812…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Millet Seed Extract (millet seed extract)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Telogen Effluvium | NA | Status: COMPLETED